JohnHNadeauMD

PubMed

• 108 citations
  Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema.
  James Brian Byrd, Karine Touzin, Saba Sile, James V. Gainer, Chang Yu, John H. Nadeau, Albert Adam, Nancy J. Brown> ;Hypertension. 2008 Jan 1
• 2 citations
  Hypertension in an adolescent boy.
  Brenda Shome, Lewis S. Blevins, John H. Nadeau> ;The American Journal of the Medical Sciences. 2002 Apr 1
• 153 citations
  Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production.
  Nancy J. Brown, Kyungsoo Kim, Yan Qun Chen, Lewis S. Blevins, John H. Nadeau, Steven G. Meranze, Douglas E. Vaughan> ;The Journal of Clinical Endocrinology and Metabolism. 2000 Jan 1
• 41 citations
  Clinical experience over 48 years with pheochromocytoma.
  R E Goldstein, J A O'Neill Jr, G W Holcomb 3rd, W M Morgan 3rd, W W Neblett 3rd, J A Oates, N Brown, J Nadeau, B Smith, D L Page, N N Abumrad, H W Scott Jr> ;Annals of Surgery. 1999 Jun 1
• 12 citations
  Angiotensin II type I receptor polymorphism in African Americans lower frequency of the C1166 variant.
  James V. Gainer, Tracy E. Hunley, Valentina Kon, John H. Nadeau, James A.S. Muldowney, Nancy J. Brown> ;Biochemistry and Molecular Biology International. 1997 Sep 1
• 123 citations
  Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin.
  Nancy J. Brown, John H. Nadeau, Douglas E. Vaughan> ;Thrombosis and Haemostasis. 1997 Mar 1
• 28 citations
  Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin.
  Nancy J. Brown, Diane Ryder, James V. Gainer, Jason D. Morrow, John H. Nadeau> ;The Journal of Pharmacology and Experimental Therapeutics. 1996 Nov 1
• 72 citations
  Increased sensitivity to bradykinin among African Americans.
  James V. Gainer, John H. Nadeau, Diane Ryder, Nancy J. Brown> ;The Journal of Allergy and Clinical Immunology. 1996 Aug 1
• 65 citations
  Baroreflex failure in a patient with central nervous system lesions involving the nucleus tractus solitarii.
  Italo Biaggioni, W O Whetsell, J Jobe, John H. Nadeau> ;Hypertension. 1994 Apr 1
• 43 citations
  Simplified assay for the quantification of 2,3-dinor-6-ketoprostaglandin F1α by gas chromatography—mass spectrometry
  Vincent C. Daniel, Tanya A. Minton, Nancy J. Brown, John H. Nadeau, Jason D. Morrow> ;Journal of Chromatography. B, Biomedical Applications. 1994 Mar 4
• 9 citations
  Does Race Predispose to Angiotensin-Associated Angioneurotic Edema?
  Nancy J. Brown, John H. Nadeau> ;Annals of Internal Medicine. 1993 Dec 15
• 16 citations
  Caffeine attenuates the renal vascular response to angiotensin II infusion.
  Nancy J. Brown, Diane Ryder, John H. Nadeau> ;Hypertension. 1993 Dec 1
• 8 citations
  The effects of clonidine hydrochloride versus atenolol monotherapy on serum lipids, lipid subfractions, and apolipoproteins in mild hypertension
  Mark C. Houston, Candice Burger, James Taylor Hays, John H. Nadeau, Larry L. Swift, Charles A. Bradley, Laurie Olafsson> ;American Heart Journal. 1990 Jul 1
• 50 citations
  Low sodium intake corrects abnormality in β‐receptor–mediated arterial vasodilation in patients with hypertension: Correlation with β‐receptor function in vitro
  Thomas C. Naslund, David J. Silberstein, Walter J Merrell, John H. Nadeau, Alastair J. J. Wood> ;Clinical Pharmacology and Therapeutics. 1990 Jul 1
• 9 citations
  α-Adrenergic blockade makes minimal contribution to ketanserin's hypotensive effect
  Thomas C. Naslund, W J Merrell, John H. Nadeau, Alastair J. J. Wood> ;Clinical Pharmacology and Therapeutics. 1988 Dec 1
• 6 citations
  Electrophysiologic and hemodynamic effects of chronic oral therapy with the α2‐agonists clonidine and tiamenidine in hypertensive volunteers
  Dan M. Roden, John H. Nadeau, R.Kirby Primm> ;Clinical Pharmacology and Therapeutics. 1988 Jun 1
• Join now to see all